Conestoga Capital Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Conestoga Capital Advisors, LLC

$7.22 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$102.33 - $144.73 $45.1 Million - $63.8 Million	-440,802 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$113.03 - $155.64 $6.23 Million - $8.57 Million	-55,079 Reduced 11.11%	440,802 $57.8 Million
Q1 2021 Apr 23, 2021	SELL	$99.52 - $215.83 $22 Million - $47.6 Million	-220,559 Reduced 30.79%	495,881 $75.6 Million
Q4 2020 Jan 26, 2021	BUY	$80.55 - $106.05 $567,233 - $746,804	7,042 Added 0.99%	716,440 $71.3 Million
Q3 2020 Oct 23, 2020	BUY	$89.56 - $126.72 $3.28 Million - $4.64 Million	36,630 Added 5.44%	709,398 $67.6 Million
Q2 2020 Aug 03, 2020	BUY	$68.28 - $123.65 $1.65 Million - $2.99 Million	24,165 Added 3.73%	672,768 $75.2 Million
Q1 2020 Apr 17, 2020	BUY	$63.37 - $107.88 $1.83 Million - $3.12 Million	28,950 Added 4.67%	648,603 $47.2 Million
Q4 2019 Jan 24, 2020	SELL	$96.94 - $113.59 $1.26 Million - $1.48 Million	-13,041 Reduced 2.06%	619,653 $64.6 Million
Q3 2019 Oct 25, 2019	SELL	$86.25 - $120.16 $345,431 - $481,240	-4,005 Reduced 0.63%	632,694 $63 Million
Q2 2019 Aug 02, 2019	BUY	$107.38 - $129.34 $1.69 Million - $2.03 Million	15,693 Added 2.53%	636,699 $72.7 Million
Q1 2019 Apr 18, 2019	BUY	$105.93 - $142.47 $14.2 Million - $19.1 Million	134,173 Added 27.56%	621,006 $78.1 Million
Q4 2018 Jan 28, 2019	SELL	$128.36 - $272.13 $10.2 Million - $21.6 Million	-79,390 Reduced 14.02%	486,833 $66.1 Million
Q3 2018 Oct 25, 2018	BUY	$211.18 - $274.49 $13.6 Million - $17.7 Million	64,329 Added 12.82%	566,223 $155 Million
Q2 2018 Jul 20, 2018	BUY	$150.77 - $207.98 $4.73 Million - $6.52 Million	31,364 Added 6.67%	501,894 $104 Million
Q1 2018 Apr 24, 2018	SELL	$138.63 - $182.62 $2.68 Million - $3.52 Million	-19,300 Reduced 3.94%	470,530 $77.7 Million
Q4 2017 Jan 22, 2018	BUY	$128.36 - $147.04 $7.28 Million - $8.34 Million	56,705 Added 13.09%	489,830 $67.1 Million
Q3 2017 Oct 20, 2017	BUY	$120.91 - $137.94 $52.4 Million - $59.7 Million	433,125	433,125 $59 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Account